Sacrocolpopexy Using Polyvinylidene Fluoride Mesh: A Systematic Review and Meta‐Analysis Authors: Mahdi Norouzi, Mahtab Zargham, Farshad Gholipour, Shayan Ghanouni, Raheleh Karimi, Farshid Alizadeh, Karuna Sharma Published: 2026 ABSTRACT AbstractBackground and AimsThis review aimed to assess the clinical outcomes and complications of polyvinylidene fluoride (PVDF) mesh in sacrocolpopexy (SCP).MethodsA systematic search was conducted on Google Scholar, PubMed, Web of Science, Scopus, and Embase up to October 2024. All study designs employing PVDF mesh in SCP were included. Demographic features, mesh types, surgical method, surgical outcomes, and mesh exposure, among other outcomes and complications, were extracted by two independent researchers. The registered protocol is available online on PROSPERO (ID: CRD42023405734).ResultsOut of 319 studies screened, 12 were finally included in the systematic review and meta‐analysis, encompassing 1093 female patients who underwent SCP. Four studies employed polypropylene (PP) as the comparator. Abdominal sacrocolpopexy (ASC) was used by six studies, five adhered to the laparoscopic method and one used both. Meta‐analysis indicated pooled prevalence rates close to 0% for mesh exposure, recurrence, sexual dysfunction (SD), and reoperation in the PVDF group; however, small sample sizes and wide confidence intervals diminish the definitive conclusion. The prevalence of urge urinary incontinence (UUI) was 33%, while both stress urinary incontinence (SUI) and de novo incontinence had a prevalence of 6%. However, the differences between PVDF and PP outcomes and complications were not statistically significant.ConclusionNo significant differences were found between PVDF mesh and PP. Our findings highlight the need for further robust evidence to indicate the possible differences between PVDF and conventional materials, especially PP.Keywords: pelvic organ prolapse, polypropylene, polyvinylidene fluoride, sacrocolpopexy, synthetic mesh 1. Introduction Approximately 30% of US females aged between 50 and 89 years old are affected by pelvic organ prolapse (POP), a condition characterized by the anatomical disposition of the pelvic organs and bulging through the vagina [1]. The prevalence of POP is expected to rise progressively, even up to 50% by 2050 [2]. POP significantly affects women’s quality of life [3]. About 73% of POP patients suffer from urine incontinence, 86% from urinary urgency, 34%–62% from voiding dysfunction, and 31% suffer from fecal incontinence (according to integral theory) [4]. Open abdominal sacrocolpopexy (ASC), introduced by Lane in 1962 [5], remains the gold standard procedure for high‐grade apical POP repair [6]. However, recent studies encompassing laparoscopic and robotic procedures reflect relatively superior functional and anatomical outcomes [7, 8]. Sacrocolpopexy (SCP), according to Cochrane, has demonstrated superior long‐term outcomes compared with vaginal sacrospinous ligament fixation although it requires longer operative and recovery times [9]. Meta‐analysis comparing SCP with transvaginal mesh surgery found lower mesh‐related complication rates, prolapse recurrence, and de novo dyspareunia. Nonetheless, side effects are inevitable: reoperation rates range from 2.3% in clinical studies [10] to 29.2% in large administrative datasets [11]. A systematic review including 71 RCTs indicated 110 different complications of the procedure, with erosion (78% of studies), pain (56%), bleeding (61%), and dyspareunia (49%) being the most common ones [12]. Polyvinylidene fluoride (PVDF) mesh, first introduced in 2002 [13], has emerged as an alternative to polypropylene (PP) [14]. A histological study on sheep showed higher biocompatibility of PVDF compared with PP [15]. Additionally, PVDF has shown no sign of degradation phenomenon (cracking and flaking on the surface of mesh), a growing concern in long‐term mesh safety, even after 24 months of follow‐up [16]. Contrary to PVDF, PP showed progressive degradation at the same time, which may account for the corresponding privileges [17]. The present study aims to systematically review and meta‐analyze the current literature on SCP using PVDF mesh to provide robust evidence on the clinical application of PVDF. 2. Methods 2.1. Search Strategy Google Scholar, PubMed (MEDLINE), Web of Science, Scopus, and Embase were systematically searched up to October 2024 using the following search line: ((“Sacrocolpopexy” OR “Sacral colpopexy”) AND (“PVDF” OR “Polyvinylidene fluoride”)). The search strategy was tailored to each of the databases (detailed search string for each of the databases is available in the supporting materials). Studies were then restricted to the English language, and duplicates were deleted. No time limitation was considered. This review was conducted following the 2020 version of Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines [18]. The registered protocol is available on PROSPERO (ID: CRD42023405734). 2.2. Inclusion and Exclusion Criteria Followed by the search strategy, all types of studies on POP repair using SCP and PVDF mesh were included without restrictions on time, region, or age. Only human studies were included. Exclusion criteria were as follows: non‐English studies, review articles, case reports, conference abstracts, and studies using multiple mesh types without adequate details. 2.3. Study Selection and Data Extraction Studies were screened and extracted by two independent researchers (MN and FGH), and controversies were solved through mutual discussion. The data extraction items were as follows: first author, country, publication date, study design, participants, sex, age, duration of follow‐up, mesh type, operation features, surgical procedure, pre‐ and postoperative data, anatomical and functional outcomes, mesh exposure, and other side effects (when applicable). Discrepancies regarding study selection, data extraction, analyses, and risk of bias (ROB) assessment were resolved through joint discussion. 2.4. Quality Assessment ROB assessment was conducted by two independent researchers, and any disagreements were resolved through discussion. We used the Newcastle–Ottawa Scale (NOS) tool. Risk assessment categories encompass selection bias, comparability, exposure (for case controls), and outcome (for cohort/cross sections). Using the scores from each category, the overall score was computed, and studies were then categorized into low risk, unclear, or high risk based on their respective scores. 2.5. Statistical Analysis Statistical analysis was conducted using STATA 16.0 (StataCorp, College Station, TX, USA). Descriptive statistics were used to summarize study characteristics. Continuous variables were expressed as mean ± standard deviation (SD) and categorical variables as frequency (n) and percentage (%). Meta‐analysis was used for both, pooling the prevalence of PVDF outcomes and comparing the outcomes of PVDF versus PP. For analysis with more than 10 studies, publication bias was assessed visually via funnel plots and, where applicable, statistically via Egger’s regression test [19]. In the prevalence meta‐analysis, the pre‐ and postoperative incidence of each outcome was either extracted or calculated and used for meta‐analysis. Incidence of the functional and anatomical outcomes was compared with the respective preoperative incidence. For the de novo incontinence outcome, the incidence was compared with the crude baseline participants of each study. All statistical tests were two sided, and a p value < 0.05 was considered statistically significant. ORs are presented with 95% confidence intervals (CIs). 3. Results 3.1. Study Selection The study selection process is summarized in Figure 1. Based on the search strategy, 363 records were identified, and after excluding duplicates, 242 papers remained for further screening. Titles and abstracts were carefully screened by two researchers, and 48 papers underwent full‐text screening. Finally, 12 studies were included in the systematic review and meta‐analysis. PRISMA flowchart of included studies in systematic review and meta‐analysis. 3.2. Characteristics of Included Studies Table 1 summarizes the characteristics of the included studies. Of 12 studies, 10 were cohort [14, 20–28], one was an RCT [29] and 1 was a case–control [30]. The publication year ranged between 2015 and 2023 [14, 24]. Mean follow‐up duration was 50.9 months for PVDF and 53 months for PP, ranging between 4 and 410 months [27, 29]. Overall, 1093 female patients who underwent SCP were included. The largest study was conducted on 210 females, while the smallest encompassed 10 females [20, 23]. Six studies used ASC [14, 21, 24, 25, 28, 29], five used laparoscopic procedures [20, 22, 23, 26, 27], and one used both [30]. Four studies used PP mesh as the PVDF comparator. The main outcomes of the studies were functional and anatomical and mesh complications. TABLE 1Characteristics of included studies.StudyRegionDesignPopulationAge (mean, year)MeshFollow‐up (months)ProcedureBalsamo et al., [30]ItalyRetrospective case‐control136 (PVDF: 63, PP: 73)PP: 68.97, PVDF: 67.96PVDF ∗ vs. PP ∗∗ PVDF: 25.6, PP: 94Laparoscopic or openJoukhadar et al., [20]Germanycohort1062PVDF12LaparoscopicRajshekhar et al., [21]UKRetrospective cohort5066PVDF13OpenKavallaris et al., [22]GreeceRetrospective cohort172 (PVDF: 90, PP: 82)PVDF: 59.5, PP: 61.2PVDF vs. PPPVDF: 41, PP: 54LaparoscopicCallewaert et al., [23]BelgiumCohort210 (PVDF = 105, PP = 105)PVDF: 67, PP: 68PVDF vs. PP + PGPVDF: 26, PP: 46LaparoscopicJaeger et al., [24]GermanyCohort7664.9PVDF20OpenCassis et al., [25]UKRetrospective cohort10065.2PVDF12OpenLudwig et al., [28]GermanyRetrospective cohort7164PVDF16OpenEisenberg et al., [26]IsraelRetrospective cohort42 (PVDF: 25, PP: 17)PVDF: 62.16, PP: 56.82PVDF vs. PP18Laparoscopicde Castro et al., [29]BrazilRCT7164.5PVDF410.2OpenRexhepi et al., [27]Germanycohort12066PVDF4LaparoscopicZargham et al., [14]Irancohort3559.9PVDF12Open ∗PVDF: polyvinylidene fluoride. ∗∗PP: polypropylene. Characteristics of included studies. ∗PVDF: polyvinylidene fluoride. ∗∗PP: polypropylene. 3.3. Synthesis of Results Functional outcomes of SCP were categorized and analyzed in six categories: stress urinary incontinence (SUI), urge urinary incontinence (UUI), storage symptoms (SS), voiding symptoms (VS), sexual dysfunction (SD), and dysfunctions occurring postoperation (de novo urinary incontinence). 3.4. Prevalence of Outcomes Table 2 presents a summary of the results included in the prevalence meta‐analysis. The pooled meta‐analysis showed the prevalence of mesh extrusion as 0% (Figure S1). Likely, the pooled prevalence of POP recurrence, SD, and reoperation was 0% (Figures S2, S3, and S4). Persistence of UUI after the operation, with a pooled prevalence of 33%, was the most prevalent postoperative complication (Figure S5). Both SUI and de novo incontinence had a prevalence of 6% among patients (Figures S6 and S7). Publication bias assessment using funnel plots and Egger’s regression test was performed for mesh extrusion and reoperation prevalence (with 10+ studies). Funnel plots are presented in Figures S8 and S9. Egger’s test revealed no evidence of small study effects (i.e., publication bias) for mesh extrusion (p = 0.33) and reoperation (p = 0.24). TABLE 2Incidence of PVDF mesh outcomes.StudyMesh erosion (%)Recurrence (%)Reoperation (%)De novo urinary incontinence (%)Stress urinary incontinence (%)Urge urinary incontinence (%)Sexual dysfunction (%)Storage symptoms (%)Voiding symptoms (%)Balsamo et al., [30]1.614.303.120.771.40013Kavallaris et al., [22]0007.839.118.44.33.10Callewaert et al., [23]1.9 1.9 32.141.150 Rajshekhar et al., [21]02289 0 Joukhadar et al., [20]01001016.6 Rexhepi et al., [27]0 30.7 Zargham et al., [14]017.15.75.7 de Castro et al., [29]5.632.47 Jaeger et al., [24]06.66.6 Cassis et al., [25]2124 Eisenberg et al., [26]000 Ludwig et al., [28]0 Incidence of PVDF mesh outcomes. 4. PVDF vs. PP 4.1. Functional Outcomes SUI: SUI was reported in three studies. Although the incidence of SUI after SCP with PVDF was lower than PP, the results were not statistically significant (OR = 0.64 [CI 95%: 0.34, 1.21], p = 0.86) (Figure 2). Forest plot of meta‐analysis and subgroup meta‐analysis of PVDF vs. PP outcomes. UUI: Similar to SUI, UUI was reported in 3 studies. Thirty‐six percent of all patients in the PVDF group and 38.6% of the PP group had UUI symptoms after surgery. However, the differences between groups were not statistically significant (OR = 0.90 [CI 95%: 0.48, 1.66], p = 0.72) (Figure 2). SD: Although the rates of SD after surgery were lower in the PVDF group than in PP, the results did not show a statistically significant difference (OR = 0.29 [CI 95%: 0.07, 1.28], p = 0.31) (Figure 2). SS: SS was reported in two studies, and rates were lower for PVDF compared with PP in both studies. However, the differences were not statistically significant (OR = 0.32 (0.07, 1.40), p = 0.37) (Figure 2). VS: Persistence of VS after surgery was reported in two studies, which reported conflicting results. The differences were not statistically significant (OR = 0.69 [CI 95%: 0.48, 1.66], p = 0.72) (Figure 2). De novo urinary dysfunctions were defined as new occurrences of urinary dysfunctions postoperatively, which were reported by two studies. The overall differences between PVDF and PP were not statistically significant (OR = 0.58 [CI 95%: 0.22, 1.55], p = 0.57) (Figure 2). The overall differences between the functional outcomes of PVDF compared with PP were not statistically significant (OR = 0.69 [CI 95%: 0.48, 0.98], p = 0.68) (Figure 2). 4.2. Mesh Exposure Out of four studies that reported mesh complications in both PVDF and PP, three studies indicated a lower incidence of exposure in PVDF compared with PP. The crude incidence of exposure was 1% and 2.5% in the PVDF vs. PP group, respectively. However, the results did not show a statistically significant difference (OR = 0.60 (0.15, 2.41), p = 0.47) (Figure 3). Forest plot of PVDF vs. PP mesh extrusion. 4.3. ROB Assessment The ROB assessment was conducted using the NOS tool and is illustrated in Figures 4 and 5 [31]. Concerns regarding comparability affected all studies. Most studies on other categories indicated good performance. Summary of risk of bias assessment for RCT (the upper table) and cohort studies (the lower table). Risk of bias graphs for (a) RCT and (b) cohort studies. 5. Discussion The present systematic review aimed to investigate the outcomes of SCP using PVDF mesh in the treatment of POP and compare the outcomes with PP mesh as an auxiliary investigation. However, there were no statistically significant differences between the two mesh types. Further studies are required to elucidate the differences between mesh types. Various factors, such as concomitant procedures, surgical approach, surgeon experience, and patients’ conditions, can contribute to complications and may significantly influence outcomes. The inability to control these confounding factors in our study may have impacted the observed results. Additionally, most of the included studies were observational, which is prone to potential confounding by indication. For instance, surgeon preferences, complexity of the surgical method, or patients’ characteristics are influential factors in choosing mesh material and surgical endpoints. Although some studies highlight the advantages of PVDF over PP, statistical significance was not achieved in our meta‐analysis. Although meta‐analysis indicated a pooled prevalence of 0% for mesh extrusion, recurrence, reoperation, and SD, the results were not statistically significant compared with PP. Additionally, the small number of included studies and wide CIs diminish the strong conclusion on this matter; further robust studies are required to draw more confident evidence. On the other hand, these procedures were performed by experienced surgeons in advanced centers, which may limit the generalizability. Similar to our study, a systematic review on PVDF vs. PP mesh types in POP/UI encompassing three studies on POP surgery reported no differences between mesh outcomes, except for de novo urgency and de novo sexual dysfunction; however, this significant difference was not replicated in our study [32]. Among 816 PVDF patients with a mean follow‐up of 50.9 months, only nine (1.1%) experienced mesh extrusion, a rate lower than what has been reported in other reviews for synthetic mesh extrusion [33]. Additionally, one superiority of PVDF compared with PP is radiologic visibility. Kavallaris and Zygouris [22] reported PVDF’s privilege in the early diagnosis of intraoperative injuries through MRI visibility. Unlike PVDF, PP mesh is not easily visualized on imaging modalities. Several limitations affected our study. First, small sample sizes reduce the statistical power and robustness of the outcomes. Second, the short to moderate follow‐up durations in available studies restrict the ability to assess long‐term safety and durability of PVDF mesh in POP repair. Third, there was substantial heterogeneity in outcome definitions, surgical techniques, and reporting standards, which complicates direct comparisons and meta‐analytic synthesis. Fourth, the lack of adjustment for potential confounding factors—such as patient age, comorbidities, prolapse stage, and surgeon experience—may have influenced the reported outcomes. Despite the limitations, the present study highlights the relevance of mesh type selection in POP repair surgery. Furthermore, the study underscores the need for more robust studies, especially randomized controlled trials involving larger patient populations with extended follow‐up periods. Future research should compare PVDF mesh outcomes with other synthetic meshes and nonmesh approaches in POP repair. 6. Conclusions In conclusion, no significant differences were found between PVDF mesh and PP. However, beyond the surgical outcomes, PVDF has shown promising results in animal studies. Also, PVDF has shown superiority in terms of mesh imaging, which is crucial in postoperation settings. Finally, we strongly recommend conducting further robust studies comparing different mesh materials in POP repair, particularly the PVDF and PP. Funding No funding was received for this manuscript. Disclosure All authors have read and approved the final version of the manuscript, the corresponding author has full access to all of the data in this study, and takes complete responsibility for the integrity of the data and the accuracy of the data analysis. The corresponding author affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. Conflicts of Interest The authors declare no conflicts of interest. Supporting Information Additional supporting information can be found online in the Supporting Information section. Supporting information Supporting Information Supporting File 1 (Search strings.docx): This document contains the exact search strategies applied to PubMed, Scopus, Web of Science, Embase, and Google Scholar for the systematic literature review. Figure S1. Forest plot of prevalence of mesh extrusion in PVDF patients. Figure S2. Forest plot of prevalence of prolapse recurrence in PVDF patients. Figure S3. Forest plot of prevalence of reoperation in PVDF patients. Figure S4. Forest plot of prevalence of sexual dysfunction in PVDF patients. Figure S5. Forest plot of prevalence of urge urinary incontinence in PVDF patients. Figure S6. Forest plot of prevalence of stress urinary incontinence in PVDF patients. Figure S7. Forest plot of prevalence of de novo urinary incontinence in PVDF patients. Figure S8. Funnel plot of mesh extrusion prevalence. Figure S9. Funnel plot of reoperation prevalence. Acknowledgments The authors have nothing to report. Norouzi, Mahdi , Zargham, Mahtab , Gholipour, Farshad , Ghanouni, Shayan , Karimi, Raheleh , Alizadeh, Farshid , Sacrocolpopexy Using Polyvinylidene Fluoride Mesh: A Systematic Review and Meta‐Analysis, Advances in Urology, 2026, 1620419, 10 pages, 2026. 10.1155/aiu/1620419 Academic Editor: Karuna Sharma Contributor Information Farshad Gholipour, Email: gholipour@med.mui.ac.ir. Karuna Sharma, Email: kasharma@wiley.com. Data Availability Statement The authors confirm that the data supporting the findings of this study are included within the article and/or its supporting materials. References Associated Data Supplementary Materials Supporting Information Supporting File 1 (Search strings.docx): This document contains the exact search strategies applied to PubMed, Scopus, Web of Science, Embase, and Google Scholar for the systematic literature review. Figure S1. Forest plot of prevalence of mesh extrusion in PVDF patients. Figure S2. Forest plot of prevalence of prolapse recurrence in PVDF patients. Figure S3. Forest plot of prevalence of reoperation in PVDF patients. Figure S4. Forest plot of prevalence of sexual dysfunction in PVDF patients. Figure S5. Forest plot of prevalence of urge urinary incontinence in PVDF patients. Figure S6. Forest plot of prevalence of stress urinary incontinence in PVDF patients. Figure S7. Forest plot of prevalence of de novo urinary incontinence in PVDF patients. Figure S8. Funnel plot of mesh extrusion prevalence. Figure S9. Funnel plot of reoperation prevalence. Data Availability Statement The authors confirm that the data supporting the findings of this study are included within the article and/or its supporting materials.